Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Foamy Histiocyte-like Esophageal Adenocarcinoma: Unusual Morphology and Diagnostic Pitfalls

FENG YIN, JINHUA PIAO, XIULI LIU and JINPING LAI
Anticancer Research October 2018, 38 (10) 5999-6002; DOI: https://doi.org/10.21873/anticanres.12948
FENG YIN
1Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JINHUA PIAO
2Department of Pathology, St. Louis University School of Medicine, St. Louis, MO, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
XIULI LIU
1Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JINPING LAI
1Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jinpinglai@ufl.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

In the United States and other western countries, the vast majority of primary esophageal malignancies are adenocarcinomas arising in the lower esophagus within a background of Barrett's esophagus. The microscopic feature of esophageal adenocarcinoma varies, with the tubular or papillary adenocarcinoma of intestinal pattern being the most common, and other less common morphological patterns include adenosquamous, signet ring cell, mucinous, mucoepidermoid, and adenoid cystic carcinoma. This is a case report of esophageal adenocarcinoma with foamy histiocyte-like feature in a 71-year-old male with a history of smoking and Barrett's esophagus who presented with dysphagia and weight loss. The tumor cells showed an abundant foamy cytoplasm, low N/C ratio and irregular nuclear contour. They were arranged in single, trabecular and glandular patterns and deeply invaded adventitia. Lymphovascular invasion and perineural invasion were present. The foamy histiocyte like–tumor cells were negative for CD68, but strongly and diffusely positive for CK7. E-Cadherin was maintained in the tumor cells, and p53 immunostaining revealed a wild-type staining pattern. To the best of our knowledge, this is the first documented case of primary esophageal adenocarcinoma with foamy-histiocyte-like phenotype. The clinical course, diagnosis and prognosis of this entity are discussed.

  • Esophageal adenocarcinoma
  • foamy histiocyte-like
  • Barrett's esophagus
  • immunohistochemistry

The prevalence, incidence and associated mortality of esophageal adenocarcinoma have been increasing over the past several decades (1, 2). In the United States, the vast majority of primary esophageal malignancies are adenocarcinomas arising in the lower esophagus or esophagogastric junction within a background of Barrett's esophagus (BE), although many new diagnostic cancer patients have no reported history of BE or heartburn (2, 3).

Clinically the signs and symptoms of esophageal adenocarcinoma include dysphagia, weight loss, chest pain, heartburn, and coughing/hoarseness. The microscopic feature of esophageal adenocarcinoma varies, with the tubular or papillary adenocarcinoma of intestinal pattern being the most common, and other less common morphological patterns include adenosquamous, signet ring cell, mucinous, mucoepidermoid, and adenoid cystic carcinoma. Carcinomas with foamy histiocyte-like features have been reported in the prostate, pancreas, breast and liver cancers, but not in esophagus adenocarcinomas (4).

In this paper we present a case of an unusual esophageal adenocarcinoma with foamy histiocyte-like feature of the distal esophagus in a 71-year-old male who had a history of smoking, Barrett's esophagus and neoadjuvant chemoradiation therapy, and discuss the diagnosis and its potential pitfall. To the best of our knowledge, this is the first documented case of primary esophageal adenocarcinoma with foamy-histiocyte-like phenotype. The clinical course, diagnostic pitfalls and prognosis of this entity are discussed.

Case Presentation

The patient was a 71-year-old male former heavy smoker with a past medical history of hypertension, diabetes mellitus type 2, coronary artery disease status post coronary artery bypass grafting, and Barrett's esophagus. He received esophageal dilation in 2011 due to dysphagia. Over the past 2 months he again developed dysphagia for solid food and had lost about 5 pounds of body weight. Esophagogastroduodenoscopy revealed an ulcerated lesion extended from 34 cm to 39 cm just beyond the gastroesophageal junction. The biopsy revealed an invasive adenocarcinoma. The patient underwent a course of neoadjuvant chemoradiation therapy. His computed tomography (CT) scan showed distal esophageal thickening with no signs of metastasis (Figure 1A). The PET/CT scan similarly showed distal esophageal thickening with increased 18F-Fluorodeoxyglucose (FDG) avidity (Figure 1B). There was no extra esophageal FDG avidity suggestive of metastatic disease. The endoscopic ultrasound revealed a stricture at 38 cm that the scope could not be passed beyond. Esophagogastrectomy was performed and the specimen was submitted for pathological evaluation.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Imaging findings of esophageal carcinoma. A: Computed tomography (CT) scan showing distal esophageal wall thickening (arrow); B: The PET/CT scan similarly showing distal esophageal thickening with increased 18F-Fluorodeoxyglucose (FDG) avidity (arrow).

In pathology, grossly the specimen consisted of a limited resection of 9.2 cm-segment including distal esophagus, cardia, and proximal stomach (Figure 2A). The length of the esophagus portion was 5.2 cm with a circumference of 3.5 cm. The stomach portion measured 4.0 cm in length and 7.5 cm in circumference. There was an ulcerated lesion (2.5 x 1.5 cm) in the gastroesophageal junction (GEJ), which measured 0.4 cm in depth and was 0.8 cm from the adventitial margin.

Microscopically there were focal residual tumor cells in a fibrotic stroma, consistent with response to the chemoradiation therapy. The tumor cells had low nuclear to cytoplasmic ratio and foamy cytoplasm (foamy histiocyte-like or “fried-egg” appearance), few tumor cells had large cytoplasmic vacuole (Figure 2B). Nuclear atypia was present. Cords and glandular arrangement of the foamy tumor cells were also present (Figure 2C). During intraoperative consultation, tumor cells involved both proximal and distal resection margins. Residual foamy tumor cells also deeply invaded the adventitia. Final resection margins were negative for carcinoma on additionally taken tissue. Lymphovascular invasion and perineural invasion were present. Uninvolved gastric and esophageal mucosa revealed changes consistent with reactive gastropathy and radiation esophagitis with ulceration.

Fourteen regional lymph nodes were identified, and two of them were positive for rare tumor cells morphologically mimicking foamy histiocytes (Figure 2D), cytokeratin AE1/AE3 immunostaining highlighted these tumor cells in the small lymph node. The foamy histiocyte like-tumor cells were negative for CD68, but they were strongly and diffusely positive for CK7. E-cadherin was maintained in the tumor cells with histocyte-like features. Immunostaining for p53 revealed a wild-type staining pattern. The final diagnosis was invasive adenocarcinoma with histiocyte-like features (yrpT3N1). Post-surgery, his subsequent clinical course was complicated by respiratory failure, tracheoesophageal fistula development and multiple episodes of aspiration pneumonia. On one year follow-up, he was appropriately treated and stayed in a stable condition without recurrence or metastasis identified in imaging findings.

Discussion

Esophageal adenocarcinoma is one of the most lethal malignancies in the gastrointestinal system and its incidence has increased approximately 600% during the past 40 years (1, 2). The American Cancer Society's estimates, in the United States for 2018, about 17,290 new diagnoses of esophageal cancer cases, and about 15,850 deaths from esophageal cancer (https://www.cancer.org/cancer/esophagus-cancer/about/key-statistics.html). Barrett's esophagus is the major risk fact for esophageal adenocarcinoma with dysplasia being the most recognized factor for cancer risk stratification (5). Other risk factors include smoking, alcohol, gastroesophageal reflux disease, obesity, and history of radiation therapy. Currently esophagogastrectomy is the standard therapy, sometime with the preoperative neoadjuvant chemoradiation therapy for locally advanced esophageal cancer. The prognosis of esophageal adenocarcinoma is poor, and its 5-year survival rate is about 20%. Histological evidence of residue tumor cells after neoadjuvant therapy is an important prognostic factor. Sarcopenia may also worsen the long-term survival of patients with unresectable locally advanced esophageal cancer (6).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Foamy histiocyte-like esophageal adenocarcinoma. A: Grossly, the esophagogastrectomy specimen showing an ulcerated lesion at the GE junction; B-D: Microscopically, single tumor cells (arrows) (B) and tumor glands with foamy cytoplasm (C) present in the stroma and small clusters of tumor cells (arrows) present in the lymph node (D) with AE1/AE3 immunoreactivity (D, inset upper 400×). (H&E stain, B, 100×; C, 400×; D, 40×, inset lower, 400×).

Microscopically esophageal adenocarcinoma has a wide range of glandular differentiation, with intestinal phenotype being the most common, and signet ring carcinoma is much less common than its gastric counterpart. Foamy histiocyte-like esophageal adenocarcinoma has not been reported in literature through PubMed search, and it may represent a diagnostic pitfall for pathologists. In the tumor bed, xanthogranuloma and infection may need to be ruled out for certain difficult cases, particularly in cases who received preoperative chemoradiation therapy as xanthogranulmatous response to extravasated mucin may occur after treatment. Metastatic foamy histiocyte-like tumor cells in the lymph nodes, as in our case, could be difficult to differentiate from reactive sinusoid histiocytes, and immunohistochemical staining for cytokeratin would be indicated in these situations.

Foamy histiocyte-like feature has been reported in different cancer types including prostatic adenocarcinoma, hepatocellular carcinoma, pancreatic intraepithelial neoplasia, pancreatic ductal adenocarcinoma, and breast adenocarcinoma (4, 7-11). Their clinical outcome is not clear due to the paucity of available information. In our case, the esophageal adenocarcinoma with foamy histiocyte-like feature had an aggressive pathological feature, with extensive involvement of adventitia, proximal and distal resection margins. Lymphovascular invasion and perineural invasion were present. Two lymph nodes were also positive for metastatic carcinoma. In the previous reports, hepatocellular carcinoma with foamy histiocyte-like feature had varied clinical outcome, and two out of three patients had a relatively better outcome as compared with conventional hepatocellular carcinoma (4, 8). However, the foamy histiocyte-like appearance of the tumor cells in our case may be due to therapy effect. Unfortunately, preoperative biopsy material was not available for review.

In summary, we report the first case of esophageal adenocarcinoma with histiocyte-like phenotype in a patient that received preoperative chemoradiation. The tumor morphology was unusual. The singly arranged or small cluster of tumor cells present in the lymph node could be misdiagnosed as reactive histiocyte post-radiation therapy. This may be the potential diagnostic pitfall for lymph node metastasis and, therefore, immunostaining for pancytokeratin is recommended. Further classification with a larger number of cases will be helpful to understand this rare and unique variant.

  • Received August 11, 2018.
  • Revision received September 5, 2018.
  • Accepted September 6, 2018.
  • Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Brown LM,
    2. Devesa SS,
    3. Chow WH
    : Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 100: 1184-1187, 2008.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Rubenstein JH,
    2. Shaheen NJ
    : Epidemiology, diagnosis, and management of esophageal adenocarcinoma. Gastroenterology 149: 302-317, 2015.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Cooper SC,
    2. El-Agib A,
    3. Dar S,
    4. Mohammed I,
    5. Nightingale P,
    6. Murray IA,
    7. Cooper BT,
    8. Trudgill NJ
    : Endoscopic surveillance for Barrett's oesophagus: the patients' perspective. Eur J Gastroenterol Hepatol 21: 850-854, 2009.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Dunn R,
    2. Zhang W,
    3. Lai J,
    4. Litton T,
    5. Zhou Y,
    6. Lai JP
    : Foamy histiocyte-like hepatocellular carcinoma (HCC): A new variant of HCC? Ann Hepatol 16: 304-307, 2017.
    OpenUrlPubMed
  5. ↵
    1. Quante M,
    2. Graham TA,
    3. Jansen M
    : Insights into the pathophysiology of esophageal adenocarcinoma. Gastroenterology 154: 406-420, 2018.
    OpenUrlPubMed
  6. ↵
    1. Sato S,
    2. Kunisaki C,
    3. Suematsu H,
    4. Tanaka Y,
    5. Miyamoto H,
    6. Kosaka T,
    7. Yukawa N,
    8. Tanaka K,
    9. Sato K,
    10. Akiyama H,
    11. Endo I
    : Impact of sarcopenia in patients with unresectable locally advanced esophageal cancer receiving chemoradiotherapy. In Vivo 32: 603-610, 2018.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Humphrey PA
    : Variants of acinar adenocarcinoma of the prostate mimicking benign conditions. Mod Pathol 31: S64-70, 2018.
    OpenUrlPubMed
  8. ↵
    1. Noro T,
    2. Gotohda N,
    3. Kojima M,
    4. Konishi M,
    5. Nakaghori T,
    6. Takahashi S,
    7. Hasebe T,
    8. Kinoshita T
    : Hepatocellular carcinoma with foamy histiocyte-like appearance: a deceptively clear cell carcinoma appearing variant. Case Rep Gastroenterol 4: 286-292, 2010.
    OpenUrlCrossRefPubMed
    1. Albores-Saavedra J,
    2. Weimersheimer-Sandoval M,
    3. Chable-Montero F,
    4. Montante-Montes de Oca D,
    5. Hruban RH,
    6. Henson DE
    : The foamy variant of pancreatic intraepithelial neoplasia. Ann Diagn Pathol 12: 252-259, 2008.
    OpenUrlCrossRefPubMed
    1. Adsay V,
    2. Logani S,
    3. Sarkar F,
    4. Crissman J,
    5. Vaitkevicius V
    : Foamy gland pattern of pancreatic ductal adenocarcinoma: a deceptively benign-appearing variant. Am J Surg Pathol 24: 493-504, 2000.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Kimura A,
    2. Miki H,
    3. Yuri T,
    4. Hatano T,
    5. Tsubura A
    : A case report of lipid-rich carcinoma of the breast including histological characteristics and intrinsic subtype profile. Case Rep Oncol 4: 275-80, 2011.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Anticancer Research: 38 (10)
Anticancer Research
Vol. 38, Issue 10
October 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Foamy Histiocyte-like Esophageal Adenocarcinoma: Unusual Morphology and Diagnostic Pitfalls
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 14 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Foamy Histiocyte-like Esophageal Adenocarcinoma: Unusual Morphology and Diagnostic Pitfalls
FENG YIN, JINHUA PIAO, XIULI LIU, JINPING LAI
Anticancer Research Oct 2018, 38 (10) 5999-6002; DOI: 10.21873/anticanres.12948

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Foamy Histiocyte-like Esophageal Adenocarcinoma: Unusual Morphology and Diagnostic Pitfalls
FENG YIN, JINHUA PIAO, XIULI LIU, JINPING LAI
Anticancer Research Oct 2018, 38 (10) 5999-6002; DOI: 10.21873/anticanres.12948
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Case Presentation
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial
  • Assessment of Breakthrough Cancer Pain Among Female Patients With Cancer: Knowledge, Management and Characterization in the IOPS-MS Study
  • Low-dose Apalutamide in Non-metastatic Castration-resistant Prostate Cancer: A Case Series
Show more Clinical Studies

Similar Articles

Keywords

  • esophageal adenocarcinoma
  • foamy histiocyte-like
  • Barrett's esophagus
  • immunohistochemistry
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire